Eur J Hosp Pharm 20:A31 doi:10.1136/ejhpharm-2013-000276.085
  • General and risk management, patient safety

GRP-085 Identification of Relevant Drug Interactions in Neonatal Intensive Care Units

  1. P Fagnoni1
  1. 1Saint Antoine Hospital (APHP), Pharmacy, Paris, France
  2. 2Dijon University Hospital, Pediatrics, Dijon, France
  3. 3Dijon University Hospital, Pharmacy, Dijon, France
  4. 4Dijon University Hospital, Regional Center of Pharmacovigilance, Dijon, France
  5. 5La Réunion University Hospital, Methodological Support Unit, La Réunion, France
  6. 6La Réunion University Hospital, Neonatology, Saint-Pierre La Réunion, France


Background Among the different types of medication errors, drug interactions may have serious consequences in Neonatal Intensive Care Units (NICU). However, they can be easily detected with appropriate tools, particularly in the context of a computerised prescribing system with pharmaceutical analysis.

Purpose The objective of this study was to calculate a theoretical criticality index, using a method inspired by the Failure Modes, Effects and Criticality Analysis (FMECA) method for each drug interactions identified in NICU in order to prioritise them to pharmacists and physicians.

Materials and Methods The study was a retrospective review of prescriptions in a French NICU. The study included prescriptions for preterm infants with gestational age below 33 weeks and hospitalised between January 2006 and December 2009. For each prescription, drug interactions were evaluated with the French Theriaque® medication database. The criticality index of each drug interaction was calculated by multiplying occurrence, severity and detection scores. The scales of each score had been built by a multidisciplinary group. Severity and detection scores were assessed by pharmacists and physicians. Intraclass Correlation Coefficients (ICCs) were used to compare pharmacists’ and physicians’ scores, and a synthesis was realised.

Results Among the 907 prescriptions with at least 2 prescribed drugs (4605 prescriptions written, with 109 different drugs), 47 different drug interactions were identified with Theriaque®. The 10 most critical drug interactions for pharmacists and physicians were detailed, and then a common medical and pharmaceutical synthesis was established. The ICC of detection was 0.75 (95% CI: 0.63–0.88), and the severity was 0.32 (95% CI: 0.08–0.56).

Conclusions This work highlights the importance of multidisciplinary collaboration in safe medication practise. This method can be used as a basis for future cooperation between medical teams and the pharmaceutical teams that make interventions. It is easily transferable to other medical specialties with the same objectives.

No conflict of interest.

EJHP blog

Analysis and discussion of the latest news, research findings and policy developments in hospital pharmacy.

Visit the blog >>

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EJHP.

View free sample issue >>

Email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article